Genetic analysis ( DrugBank: - )


6 diseases
告示番号疾患名(ページ内リンク)臨床試験数
34神経線維腫症1
85特発性間質性肺炎1
90網膜色素変性症1
93原発性胆汁性胆管炎1
94原発性硬化性胆管炎1
96クローン病1

34. 神経線維腫症


臨床試験数 : 133 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02422732
(ClinicalTrials.gov)
March 200927/3/2015Functional Imaging and Reading Deficit in Children With NF1Functional Magnetic Resonance Imaging and Reading Deficit in Children With NF1 ChildrenNeurofibromatosis Type 1Other: Neuropsychological assessments;Radiation: morphological and functional MRI (fMRI);Genetic: genetic analysisUniversity Hospital, ToulouseNULLCompleted8 Years12 YearsBoth25N/AFrance

85. 特発性間質性肺炎


臨床試験数 : 627 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03211507
(ClinicalTrials.gov)
May 1, 20172/5/2017Idiopathic Pulmonary Fibrosis Job Exposures StudyIdiopathic Pulmonary Fibrosis Job Exposures StudyIPF;Idiopathic Pulmonary FibrosisOther: Computer-assisted telephone interview;Genetic: Genetic analysisImperial College LondonWellcome Trust;University Hospital Southampton NHS Foundation Trust;Imperial College Healthcare NHS Trust;Heart of England NHS Foundation Trust;Liverpool University Hospitals NHS Foundation Trust;Papworth Hospital NHS Foundation Trust;Nottingham University Hospitals NHS Trust;University Hospital of South Manchester;Guy's and St Thomas' NHS Foundation Trust;North Bristol NHS Trust;The Leeds Teaching Hospitals NHS Trust;Newcastle-upon-Tyne Hospitals NHS Trust;Royal Devon and Exeter NHS Foundation Trust;Somerset NHS Foundation Trust;Royal Infirmary of Edinburgh;Morriston Hospital;Aberdeen Royal Infirmary;Worcestershire Acute Hospitals NHS Trust;University Hospital Birmingham NHS Foundation Trust;Portsmouth Hospitals NHS Trust;Norfolk and Norwich University Hospitals NHS Foundation Trust;Glasgow Royal InfirmaryCompletedN/AN/AMale960United Kingdom

90. 網膜色素変性症


臨床試験数 : 147 薬物数 : 176 - (DrugBank : 43) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 110
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01235624
(ClinicalTrials.gov)
March 20094/11/2010Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / GenesAutosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / GenesAutosomal Dominant Retinitis PigmentosaGenetic: genetic analysisUniversity Hospital, MontpellierMinistry of Health, FranceCompleted5 Years80 YearsBoth1161N/AFrance

93. 原発性胆汁性胆管炎


臨床試験数 : 298 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01161953
(ClinicalTrials.gov)
March 200212/7/2010Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).Primary Biliary CirrhosisGenetic: Genetic AnalysisMayo ClinicNULLActive, not recruiting18 Years90 YearsAll1500United States

94. 原発性硬化性胆管炎


臨床試験数 : 148 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01161992
(ClinicalTrials.gov)
March 200212/7/2010Genomics of Primary Sclerosing Cholangitis (PSC)P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.Primary Sclerosing Cholangitis (PSC)Genetic: Genetic AnalysisMayo ClinicNULLActive, not recruiting5 Years90 YearsAll1500United States

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02851134
(ClinicalTrials.gov)
April 20157/6/2016Search for New Genetic Mutations Major Effect in Crohn's DiseaseSearch for New Genetic Mutations Major Effect in Crohn's DiseaseCrohn DiseaseGenetic: genetic analysis;Biological: blood and stools samplesUniversity Hospital, LilleNULLCompleted5 Years80 YearsAll20France